Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase

Analytical Biochemistry

Volumn 439, Issue 2, 2013, Pages 132-141

  Jiang, Wei ^a   Murashko, Ekaterina A ^b   Dubrovskii, Yaroslav A ^b   Podolskaya, Ekaterina P ^c   Babakov, Vladimir N ^b   Mikler, John ^d   Nachon, Florian ^e   Masson, Patrick ^a,e   Schopfer, Lawrence M ^a   Lockridge, Oksana ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Russian Research Institute of Hematology and Transfusiology   (Russian Federation)

^c INSTITUTE FOR ANALYTICAL INSTRUMENTATION   (Russian Federation)

^d DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^e INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

Aged organophosphorus adducts; Human butyrylcholinesterase; Mass spectrometry; Titanium oxide

Indexed keywords

CRYSTAL STRUCTURE; DESORPTION; PEPTIDES; TITANIUM DIOXIDE; TITANIUM OXIDES;

AGED ORGANOPHOSPHORUS ADDUCTS; BUTYRYLCHOLINESTERASE; HUMAN PLASMAS; MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME OF FLIGHTS; MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY; MICRO-COLUMNS; NEGATIVE CHARGE; ORGANOPHOSPHORUS PESTICIDE;

MASS SPECTROMETRY;

CHOLINESTERASE; ORGANOPHOSPHORUS COMPOUND; PEPSIN A; SALIGENIN; TITANIUM DIOXIDE;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIGESTION; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC ACTIVATION; PRIORITY JOURNAL;

EID: 84879243247     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2013.04.018     Document Type: Article

References (50)

1. N. Allon, L. Raveh, E. Gilat, E. Cohen, J. Grunwald, Y. Ashani, Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase, Toxicol. Sci. 43 (1998) 121-128. (Pubitemid 28363385)
2. Y. Ashani, S. Shapira, D. Levy, A.D. Wolfe, B.P. Doctor, L. Raveh, Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice, Biochem. Pharmacol. 41 (1991) 37-41.
3. R. Brandeis, L. Raveh, J. Grunwald, E. Cohen, Y. Ashani, Prevention of somaninduced cognitive deficits by pretreatment with human butyrylcholinesterase in rats, Pharmacol. Biochem. Behav. 46 (1993) 889-896.
4. B.P. Doctor, A. Saxena, Bioscavengers for the protection of humans against organophosphate toxicity, Chem. Biol. Interact. 157 (158) (2005) 167-171. (Pubitemid 41757647)
5. D.E. Lenz, D.M. Maxwell, I. Koplovitz, C.R. Clark, B.R. Capacio, D.M. Cerasoli, J.M. Federko, C. Luo, A. Saxena, B.P. Doctor, C. Olson, Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys, Chem. Biol. Interact. 157 (158) (2005) 205-210. (Pubitemid 41757652)
6. H. Mumford, M.E. Price, D.M. Cerasoli, W. Teschner, H. Ehrlich, H.P. Schwarz, D.E. Lenz, Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guineapig, Chem. Biol. Interact. 187 (2010) 304-308.
7. L. Raveh, J. Grunwald, D. Marcus, Y. Papier, E. Cohen, Y. Ashani, Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity: in vitro and in vivo quantitative characterization, Biochem. Pharmacol. 45 (1993) 2465-2474. (Pubitemid 23189540)
8. L. Raveh, E. Grauer, J. Grunwald, E. Cohen, Y. Ashani, The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase, Toxicol. Appl. Pharmacol. 145 (1997) 43-53. (Pubitemid 27294768)
9. A. Saxena, W. Sun, J.M. Fedorko, I. Koplovitz, B.P. Doctor, Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX, Biochem. Pharmacol. 81 (2011) 164-169.
10. A. Saxena, W. Sun, P.A. Dabisch, S.W. Hulet, N.B. Hastings, E.M. Jakubowski, R.J. Mioduszewski, B.P. Doctor, Efficacy of human serum butyrylcholinesterase against sarin vapor, Chem. Biol. Interact. 175 (2008) 267-272.
11. A. Saxena, W. Sun, P.A. Dabisch, S.W. Hulet, N.B. Hastings, E.M. Jakubowski, R.J. Mioduszewski, B.P. Doctor, Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Gottingen minipigs exposed to sarin vapor, Biochem. Pharmacol. 82 (2011) 1984-1993.
12. D.G. Ilyushin, I.V. Smirnov, A.A. Belogurov Jr., I.A. Dyachenko, T. Zharmukhamedova, T.I. Novozhilova, E.A. Bychikhin, M.V. Serebryakova, O.N. Kharybin, A.N. Murashev, K.A. Anikienko, E.N. Nikolaev, N.A. Ponomarenko, D.D. Genkin, G.M. Blackburn, P. Masson, A.G. Gabibov, Chemical polysialylation of human recombinant butyrylcholinesterase delivers a longacting bioscavenger for nerve agents in vivo, Proc. Natl. Acad. Sci. USA 110 (2013) 1243-1248.
13. A. Fidder, A.G. Hulst, D. Noort, R. de Ruiter, M.J. van der Schans, H.P. Benschop, J.P. Langenberg, Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase, Chem. Res. Toxicol. 15 (2002) 582-590. (Pubitemid 34406420)
14. B. Li, I. Ricordel, L.M. Schopfer, F. Baud, B. Megarbane, P. Masson, O. Lockridge, Dichlorvos, chlorpyrifos oxon, and aldicarb adducts of butyrylcholinesterase detected by mass spectrometry in human plasma following deliberate overdose, J. Appl. Toxicol. 30 (2010) 559-565.
15. M. Polhuijs, J.P. Langenberg, H.P. Benschop, New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists, Toxicol. Appl. Pharmacol. 146 (1997) 156-161. (Pubitemid 27406407)
16. M.I. Solano, J.D. Thomas, J.T. Taylor, J.M. McGuire, E.M. Jakubowski, S.A. Thomson, V.L. Maggio, K.E. Holland, J.R. Smith, B. Capacio, A.R. Woolfitt, D.L. Ashley, J.R. Barr, Quantification of nerve agent VX-butyrylcholinesterase adduct biomarker from an accidental exposure, J. Anal. Toxicol. 32 (2008) 68-72. (Pubitemid 351358016)
17. D. Du, J. Wang, L. Wang, D. Lu, J.N. Smith, C. Timchalk, Y. Lin, Magnetic electrochemical sensing platform for biomonitoring of exposure to organophosphorus pesticides and nerve agents based on simultaneous measurement of total enzyme amount and enzyme activity, Anal. Chem. 83 (2011) 3770-3777.
18. F. Nachon, O.A. Asojo, G.E. Borgstahl, P. Masson, O. Lockridge, Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: the crystal structure suggests two alternative mechanisms of aging, Biochemistry 44 (2005) 1154-1162. (Pubitemid 40208995)
19. Y. Kimura, S. Shibasaki, K. Morisato, N. Ishizuka, H. Minakuchi, K. Nakanishi, M. Matsuo, T. Amachi, M. Ueda, K. Ueda, Microanalysis for MDR1 ATPase by highperformance liquid chromatography with a titanium dioxide column, Anal. Biochem. 326 (2004) 262-266. (Pubitemid 38293387)
20. P. Ruperez, A. Gago-Martinez, A.L. Burlingame, J.A. Oses-Prieto, Quantitative phosphoproteomic analysis reveals a role for serine and threonine kinases in the cytoskeletal reorganization in early T cell receptor activation in human primary T cells, Mol. Cell. Proteomics 11 (2012) 171-186.
21. S.S. Jensen, M.R. Larsen, Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques, Rapid Commun. Mass Spectrom. 21 (2007) 3635-3645. (Pubitemid 350124632)
22. O. Lockridge, L.M. Schopfer, G. Winger, J.H. Woods, Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys: a potential new therapeutic for protection against cocaine and nerve agent toxicity, J. Med. Chem. Biol. Radiol. Def. 3 (2005) doi: 10.1901/jaba.2005.3-nihms5095.
23. H. Li, L.M. Schopfer, F. Nachon, M.T. Froment, P. Masson, O. Lockridge, Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry, Toxicol. Sci. 100 (2007) 136-145. (Pubitemid 47617811)
24. F. Grueninger-Leitch, A. D'Arcy, B. D'Arcy, C. Chene, Deglycosylation of proteins for crystallization using recombinant fusion protein glycosidases, Protein Sci. 5 (1996) 2617-2622. (Pubitemid 26424874)
25. G.L. Ellman, K.D. Courtney, V. Andres Jr., R.M. Feather-Stone, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol. 7 (1961) 88-95.
26. M. Liyasova, B. Li, L.M. Schopfer, F. Nachon, P. Masson, C.E. Furlong, O. Lockridge, Exposure to tri-o-cresyl phosphate detected in jet airplane passengers, Toxicol. Appl. Pharmacol. 256 (2011) 337-347.
27. H.K. Kweon, K. Hakansson, Selective zirconium dioxide-based enrichment of phosphorylated peptides for mass spectrometric analysis, Anal. Chem. 78 (2006) 1743-1749.
28. W. Jiang, O. Lockridge, Detectable organophosphorus pesticide exposure in the blood of Nebraska and Iowa residents measured by mass spectrometry of butyrylcholinesterase adducts, Chem. Biol. Interact. 203 (2013) 91-95.
29. F. Worek, C. Diepold, P. Eyer, Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics, Arch. Toxicol. 73 (1999) 7-14. (Pubitemid 29155825)
30. P. Masson, M.T. Froment, C.F. Bartels, O. Lockridge, Importance of aspartate-70 in organophosphate inhibition, oxime re-Activation, and aging of human butyrylcholinesterase, Biochem. J. 325 (1997) 53-61. (Pubitemid 27322685)
31. M. Eto, J.E. Casida, T. Eto, Hydroxylation and cyclization reactions involved in the metabolism of tri-o-cresyl phosphate, Biochem. Pharmacol. 11 (1962) 337-352.
32. L.M. Schopfer, C.E. Furlong, O. Lockridge, Development of diagnostics in the search for an explanation of aerotoxic syndrome, Anal. Biochem. 404 (2010) 64-74.
33. E. Carletti, L.M. Schopfer, J.P. Colletier, M.T. Froment, F. Nachon, M. Weik, O. Lockridge, P. Masson, Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis, Chem. Res. Toxicol. 24 (2011) 797-808.
34. T.P. Wallis, J.J. Pitt, J.J. Gorman, Identification of disulfide-linked peptides by isotope profiles produced by peptic digestion of proteins in 50% 18O water, Protein Sci. 10 (2001) 2251-2271. (Pubitemid 32988642)
35. H. Li, I. Ricordel, L. Tong, L.M. Schopfer, F. Baud, B. Megarbane, E. Maury, P. Masson, O. Lockridge, Carbofuran poisoning detected by mass spectrometry of butyrylcholinesterase adduct in human serum, J. Appl. Toxicol. 29 (2009) 149-155.
36. H. Li, L. Tong, L.M. Schopfer, P. Masson, O. Lockridge, Fast affinity purification coupled with mass spectrometry for identifying organophosphate labeled plasma butyrylcholinesterase, Chem. Biol. Interact. 175 (2008) 68-72.
37. J. Marsillach, R.J. Richter, J.H. Kim, R.C. Stevens, M.J. MacCoss, D. Tomazela, S.M. Suzuki, L.M. Schopfer, O. Lockridge, C.E. Furlong, Biomarkers of organophosphorus (OP) exposures in humans, Neurotoxicology 32 (2011) 656-660.
38. J.L. Sporty, S.W. Lemire, E.M. Jakubowski, J.A. Renner, R.A. Evans, R.F. Williams, J.G. Schmidt, M.J. van der Schans, D. Noort, R.C. Johnson, Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum, Anal. Chem. 82 (2010) 6593-6600.
39. U.K. Aryal, C.T. Lin, J.S. Kim, T.H. Heibeck, J. Wang, W.J. Qian, Y. Lin, Identification of phosphorylated butyrylcholinesterase in human plasma using immunoaffinity purification and mass spectrometry, Anal. Chim. Acta 723 (2012) 68-75.
40. Y. Segall, D. Waysbort, D. Barak, N. Ariel, B.P. Doctor, J. Grunwald, Y. Ashani, Direct observation and elucidation of the structures of aged and nonaged phosphorylated cholinesterases by 31P NMR spectroscopy, Biochemistry 32 (1993) 13441-13450. (Pubitemid 24020218)
41. L.M. Schopfer, H. Grigoryan, B. Li, F. Nachon, P. Masson, O. Lockridge, Mass spectral characterization of organophosphate-labeled, tyrosine-containing peptides: characteristic mass fragments and a new binding motif for organophosphates, J. Chromatogr. B 878 (2010) 1297-1311.
42. B. Li, I. Ricordel, L.M. Schopfer, F. Baud, B. Megarbane, F. Nachon, P. Masson, O. Lockridge, Detection of adducts on tyrosine 411 of albumin in humans poisoned by dichlorvos, Toxicol. Sci. 116 (2010) 23-31.
43. M.J. van der Schans, A.G. Hulst, D. van der Riet-van Oeveren, D. Noort, H.P. Benschop, C. Dishovsky, New tools in diagnosis and biomonitoring of intoxications with organophosphorothioates: case studies with chlorpyrifos and diazinon, Chem. Biol. Interact. 203 (2013) 96-102.
44. V.D. Gladilovich, I.A. Krasnov, E.P. Podolskaya, Y.A. Dubrovsky, N.G. Voitenko, S.V. Fironov, V.N. Babakov, N.V. Goncharov, N.V. Krasnov, Identification of serum albumin peptides, modified by organophosphorus compounds, using methods of chromatography and mass spectrometry, Nauchnoe Priborostroenie [Scientific Instrumentation] 20 (2010) 84-92.
45. M. Wandhammer, E. Carletti, M. Van der Schans, E. Gillon, Y. Nicolet, P. Masson, M. Goeldner, D. Noort, F. Nachon, Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-Agents, J. Biol. Chem. 286 (2011) 16783-16789.
46. M.J. van der Schans, M. Polhuijs, C. Van Dijk, C.E. Degenhardt, K. Pleijsier, J.P. Langenberg, H.P. Benschop, Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE, Arch. Toxicol. 78 (2004) 508-524. (Pubitemid 39350146)
47. M.R. Larsen, T.E. Thingholm, O.N. Jensen, P. Roepstorff, T.J. Jorgensen, Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns, Mol. Cell. Proteomics 4 (2005) 873-886. (Pubitemid 41309146)
48. P.A. Connor, A.J. McQuillan, Phosphate adsorption onto TiO2 from aqueous solutions: an in situ internal reflection infrared spectrospcopic study, Langmuir 15 (1999) 2916-2921.
49. R.L. Thurlkill, G.R. Grimsley, J.M. Scholtz, C.N. Pace, PK values of the ionizable groups of proteins, Protein Sci. 15 (2006) 1214-1218.
50. C.F. Xu, Y. Lu, J. Ma, M. Mohammadi, T.A. Neubert, Identification of phosphopeptides by MALDI Q-TOF MS in positive and negative ion modes after methyl esterification, Mol. Cell. Proteomics 4 (2005) 809-818. (Pubitemid 40873009)